Gil Belofsky
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gil Belofsky has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Roberto Carreno
2 shared publications- Anthony R. Ball
Gliese 623B, Lowell, MA 01852, USA
1 shared publication David T. John
1 shared publicationGabriele Casadei
Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114
1 shared publicationGeorge P. Tegos
Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114
1 shared publicationKim Lewis
Department of Chemistry and Biochemistry, The University of Tulsa, Tulsa, Oklahoma 74101, Department of Biology, Northeastern University, Boston, Massachusetts 02115, Department of Food Science, School of Veterinary Medicine, University of Teramo, Teramo, Italy, 64100, Department of Dermatology, Harvard Medical School, Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston, Massachusetts 02114
1 shared publication
Latest Publications
- 10 February 2006
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 72 (4) , 383-386
Activity of Isoflavans ofDalea aurea(Fabaceae) against the Opportunistic AmebaNaegleria fowleri
One new and one known isoflavan, 3S(+)-7-methoxymanuifolin K (1) and manuifolin K (2), respectively, were isolated from methanolic extracts of Dalea aurea (Fabaceae). Isoflavans 1 and 2 exhibited significant in vitro activity against the ameba Naegleria fowleri, an organism responsible for an infrequent but rapidly fatal form of primary amebic meningoencephalitis (PAM). At concentrations of 30 μM, both 1 and 2 caused growth inhibition of N. fowleri at a level comparable to amphotericin B (at 0.1 μM), the currently preferred treatment for this disease. Over a seven-day growth period, 1 and 2 (30 μM) exhibited superior growth inhibition of N. fowleri than amphotericin B after day 4. Isoflavan 2 was evaluated in a mouse model of PAM at a dose of 25 mg/kg/day for five days. While amphotericin B (2.5 mg/kg/day) offered 12.5 % protection of the mice, compound 2 did not protect the mice from PAM infection compared to controls.
- 10 February 2006
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 72 (4) , 383-386
Activity of Isoflavans ofDalea aurea(Fabaceae) against the Opportunistic AmebaNaegleria fowleri
One new and one known isoflavan, 3S(+)-7-methoxymanuifolin K (1) and manuifolin K (2), respectively, were isolated from methanolic extracts of Dalea aurea (Fabaceae). Isoflavans 1 and 2 exhibited significant in vitro activity against the ameba Naegleria fowleri, an organism responsible for an infrequent but rapidly fatal form of primary amebic meningoencephalitis (PAM). At concentrations of 30 μM, both 1 and 2 caused growth inhibition of N. fowleri at a level comparable to amphotericin B (at 0.1 μM), the currently preferred treatment for this disease. Over a seven-day growth period, 1 and 2 (30 μM) exhibited superior growth inhibition of N. fowleri than amphotericin B after day 4. Isoflavan 2 was evaluated in a mouse model of PAM at a dose of 25 mg/kg/day for five days. While amphotericin B (2.5 mg/kg/day) offered 12.5 % protection of the mice, compound 2 did not protect the mice from PAM infection compared to controls.
- 12 January 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (2) , 261-264
Metabolites of the “Smoke Tree”, Dalea spinosa, Potentiate Antibiotic Activity against Multidrug-Resistant Staphylococcus aureus
Two new 2-arylbenzofuran aldehydes (1 and 2) and three known phenolic compounds (3−5) were isolated from organic extracts of Dalea spinosa. These compounds were evaluated for their intrinsic antimicrobial activity and their ability to perform as multidrug-resistance inhibitors by potentiating the activity of known antimicrobials against a variety of pathogenic microorganisms. Compound 1 and its acetate derivative 6 exhibited no direct antimicrobial activity but enhanced the effect of the weak plant antimicrobial berberine when tested against Staphylococcus aureus. Additional potentiation assays with S. aureus overexpression and knockout isogenic efflux mutants for the NorA pump were done in order to assess whether the potentiating effects were associated with inhibition of this known pump mechanism.
- 12 January 2006
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 69 (2) , 261-264
Metabolites of the “Smoke Tree”, Dalea spinosa, Potentiate Antibiotic Activity against Multidrug-Resistant Staphylococcus aureus
Two new 2-arylbenzofuran aldehydes (1 and 2) and three known phenolic compounds (3−5) were isolated from organic extracts of Dalea spinosa. These compounds were evaluated for their intrinsic antimicrobial activity and their ability to perform as multidrug-resistance inhibitors by potentiating the activity of known antimicrobials against a variety of pathogenic microorganisms. Compound 1 and its acetate derivative 6 exhibited no direct antimicrobial activity but enhanced the effect of the weak plant antimicrobial berberine when tested against Staphylococcus aureus. Additional potentiation assays with S. aureus overexpression and knockout isogenic efflux mutants for the NorA pump were done in order to assess whether the potentiating effects were associated with inhibition of this known pump mechanism.